Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 25
2025
|
William R Jellison Director |
BUY
Open market or private purchase
|
Direct |
2,500
+33.33%
|
$230,000
$92.37 P/Share
|
|
Aug 22
2025
|
William R Jellison Director |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$230,000
$92.73 P/Share
|
|
Aug 20
2025
|
Michael Marinaro EVP, Pres MedSurg and Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
1,052
-1.99%
|
$97,836
$93.22 P/Share
|
|
Aug 01
2025
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
11,594
-9.09%
|
$1,031,866
$89.34 P/Share
|
|
Aug 01
2025
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Exercise of conversion of derivative security
|
Direct |
15,249
+18.65%
|
-
|
|
Aug 01
2025
|
Matthew R. Walter SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,910
-1.95%
|
$169,990
$89.34 P/Share
|
|
Aug 01
2025
|
Matthew R. Walter SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,142
+4.54%
|
$122,538
$39.0 P/Share
|
|
Aug 01
2025
|
Denise L. Blomquist Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
515
-1.02%
|
$45,835
$89.34 P/Share
|
|
Aug 01
2025
|
Denise L. Blomquist Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
518
+1.34%
|
$13,468
$26.0 P/Share
|
|
Aug 01
2025
|
Harry Skip Kiil EVP & President Cardiovascular |
SELL
Payment of exercise price or tax liability
|
Direct |
7,555
-7.57%
|
$672,395
$89.34 P/Share
|
|
Aug 01
2025
|
Harry Skip Kiil EVP & President Cardiovascular |
BUY
Exercise of conversion of derivative security
|
Direct |
10,457
+16.8%
|
-
|
|
Aug 01
2025
|
Michael Marinaro EVP, Pres MedSurg and Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
7,763
-4.6%
|
$690,907
$89.34 P/Share
|
|
Aug 01
2025
|
Michael Marinaro EVP, Pres MedSurg and Americas |
BUY
Exercise of conversion of derivative security
|
Direct |
9,661
+7.74%
|
$376,779
$39.0 P/Share
|
|
Aug 01
2025
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
77,175
-9.21%
|
$6,868,575
$89.34 P/Share
|
|
Aug 01
2025
|
Geoffrey Martha Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
98,324
+14.69%
|
$3,834,636
$39.0 P/Share
|
|
Aug 01
2025
|
Gregory L Smith EVP Global Ops & Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
7,114
-4.37%
|
$633,146
$89.34 P/Share
|
|
Aug 01
2025
|
Gregory L Smith EVP Global Ops & Supply Chain |
BUY
Exercise of conversion of derivative security
|
Direct |
11,328
+12.0%
|
-
|
|
Jul 31
2025
|
Gregory L Smith EVP Global Ops & Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
1,630
-2.22%
|
$146,700
$90.24 P/Share
|
|
Jul 28
2025
|
Matthew R. Walter SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,350
+12.44%
|
-
|
|
Jul 28
2025
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
37,513
+14.24%
|
-
|
|
Jul 28
2025
|
Thierry Pieton EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,699
+17.88%
|
-
|
|
Jul 28
2025
|
Michelle Quinn EVP, GC and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
21,747
+46.43%
|
-
|
|
Jul 28
2025
|
Gregory L Smith EVP Global Ops & Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
9,786
+11.77%
|
-
|
|
Jul 28
2025
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
9,786
+16.02%
|
-
|
|
Jul 28
2025
|
Michael Marinaro EVP, Pres MedSurg and Americas |
BUY
Grant, award, or other acquisition
|
Direct |
9,786
+16.07%
|
-
|
|
Jul 28
2025
|
Denise L. Blomquist Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,202
+15.05%
|
-
|
|
Jul 28
2025
|
Harry Skip Kiil EVP & President Cardiovascular |
BUY
Grant, award, or other acquisition
|
Direct |
7,612
+15.56%
|
-
|
|
Jun 03
2025
|
Denise L. Blomquist Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
310
-2.97%
|
-
|
|
May 02
2025
|
Matthew R. Walter SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34
-0.13%
|
$2,856
$84.85 P/Share
|
|
Apr 29
2025
|
Elizabeth G Nabel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-1.21%
|
$18,144
$84.6 P/Share
|
|
Apr 29
2025
|
Kendall J Powell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-0.44%
|
$18,144
$84.6 P/Share
|
|
Apr 29
2025
|
Andrea Jo Goldsmith Director |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-2.06%
|
$18,144
$84.6 P/Share
|
|
Apr 29
2025
|
Randall J Hogan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-0.46%
|
$18,144
$84.6 P/Share
|
|
Apr 29
2025
|
Gregory P Lewis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-4.56%
|
$15,204
$84.6 P/Share
|
|
Apr 29
2025
|
Kevin E Lofton Director |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-2.58%
|
$18,144
$84.6 P/Share
|
|
Apr 29
2025
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-0.53%
|
$18,144
$84.6 P/Share
|
|
Apr 29
2025
|
Scott C Donnelly Director |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-0.99%
|
$18,144
$84.6 P/Share
|
|
Apr 29
2025
|
Lidia Fonseca Director |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-3.67%
|
$18,144
$84.6 P/Share
|
|
Apr 28
2025
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,083
+10.46%
|
$174,972
$84.04 P/Share
|
|
Apr 28
2025
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,083
+4.09%
|
$174,972
$84.04 P/Share
|
|
Apr 28
2025
|
Denise L. Blomquist Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,975
+22.16%
|
-
|
|
Apr 28
2025
|
Andrea Jo Goldsmith Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,083
+16.6%
|
$174,972
$84.04 P/Share
|
|
Apr 28
2025
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,083
+4.22%
|
$174,972
$84.04 P/Share
|
|
Apr 28
2025
|
Gregory P Lewis Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,083
+34.44%
|
$174,972
$84.04 P/Share
|
|
Apr 28
2025
|
Kevin E Lofton Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,083
+19.89%
|
$174,972
$84.04 P/Share
|
|
Apr 28
2025
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,083
+4.9%
|
$174,972
$84.04 P/Share
|
|
Apr 28
2025
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,083
+8.7%
|
$174,972
$84.04 P/Share
|
|
Apr 28
2025
|
Lidia Fonseca Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,083
+26.12%
|
$174,972
$84.04 P/Share
|
|
Mar 03
2025
|
Thierry Pieton EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,754
+48.15%
|
$2,890,876
$94.3 P/Share
|
|
Mar 03
2025
|
Michael Marinaro EVP, Pres MedSurg and Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
575
-1.39%
|
$54,050
$94.3 P/Share
|